Identification of HI-like loop in CELO adenovirus fiber for incorporation of receptor binding motifs

Journal of Virology

Volumn 81, Issue 18, 2007, Pages 9641-9652

  Logunov, Denis Y ^a   Zubkova, Olga V ^a   Karyagina Zhulina, Anna S ^a   Shuvalova, Eugenia A ^a   Karpov, Andrei P ^a   Shmarov, Maxim M ^a   Tutykhina, Irina L ^a   Alyapkina, Yulia S ^a   Grezina, Natalia M ^b   Zinovieva, Natalia A ^b   Ernst, Lev K ^b   Gintsburg, Alexsandr L ^a   Naroditsky, Boris S ^a  

^a GAMALEYA RESEARCH INSTITUTE OF EPIDEMIOLOGY AND MICROBIOLOGY   (Russian Federation)

^b Russian Academy of Agricultural Sciences   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; GREEN FLUORESCENT PROTEIN; VIRUS VECTOR; CXADR PROTEIN, HUMAN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RECEPTOR;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHICK EMBRYO LETHAL ORPHAN VIRUS; CONTROLLED STUDY; GENE IDENTIFICATION; GENE SEQUENCE; GENE STRUCTURE; GENE TRANSFER; IMMUNE RESPONSE; IN VIVO STUDY; MUTATION; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; ANIMAL; CHICK EMBRYO; CHICKEN; CHO CELL; COMPARATIVE STUDY; CRICETULUS; GENE THERAPY; GENETIC TRANSDUCTION; GENETICS; HAMSTER; HUMAN; METABOLISM; PROTEIN MOTIF; PROTEIN TERTIARY STRUCTURE; RABBIT;

ADENOVIRIDAE; AVIADENOVIRUS; FOWL ADENOVIRUS 1; ORYCTOLAGUS CUNICULUS;

AMINO ACID MOTIFS; ANIMALS; CHICK EMBRYO; CHICKENS; CHO CELLS; CRICETINAE; CRICETULUS; FOWL ADENOVIRUS A; GENE THERAPY; GENES, REPORTER; HUMANS; PROTEIN STRUCTURE, TERTIARY; RABBITS; RECEPTORS, VIRUS; RECOMBINANT PROTEINS; TRANSDUCTION, GENETIC; VIRAL PROTEINS;

EID: 35348871060     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00534-07     Document Type: Article

References (43)

1. Bauerschmitz, G. J., J. T. Lam, A. Kanerva, K. Suzuki, D. M. Nettelbeck, I. Dmitriev, V. Krasnykh, G. V. Mikheeva, M. N. Barnes, R. D. Alvarez, P. Dall, R. Alemany, D. T. Curiel, and A. Hemminki. 2002. Tteatment of ovarian cancer with a tropism modified oncolytic adenovirus. Cancer Res. 62:1266-1270.
2. Bauerschmitz, G. J., S. D. Barker, and A. Hemminki. 2002. Adenoviral gene therapy for cancer: from vectors to target and replication competent agent. Int. J. Oncol. 21:1161-1174.
3. Cherenova, L. V., D. Y. Logunov, E. V. Shashkova, M. M. Shmarov, L. V. Verkhovskaya, G. L. Neugodova, D. B. Kazansky, K. K. Doronin, and B. S. Naroditsky. 2004. Recombinant avian adenovirus CELO expressing the human interleukin-2: characterization in vitro, in ovo and in vivo. Virus Res. 100:257-261.
4. Cuff, J. A., M. E. Clamp, A. S. Siddiqui, M. Finlay, and G. J. Barton. 1998. Jpred: a consensus secondary structure prediction server. Bioinformatics 14:892-893.
5. Davison, E., I. Kirby, J. Whitehouse, I. Hart, J. F. Marshall, and G. Santis. 2001. Adenovirus type 5 uptake by lung adenocarcinoma cells in culture correlates with Ad5 fibre binding, is mediated by α(v)β1 integrin, and can be modulated by changes in betal integrin function. J. Gene Med. 3:550-559.
6. Davison, E., R. M. Diaz, I. R. Hart, G. Santis, and J. F. Marshall. 1997. Integrin α5β1-mediated adenovirus infection is enhanced by the integrin activating antibody TS2/16. J. Virol. 71:6204-6207.
7. Dechecchi, M. C., P. Melotti, A. Bonizzato, M. Santacatterina, M. Chilosi, and G. Cabrini. 2001. Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5. J. Virol. 18:8772-8780.
8. Dmitriev, I., V. Krasnykh, C. R. Miller, M. Wang, E. Kashentseva, G. Mikheeva, N. Belousova, and D. T. Curiel. 1998. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. J. Virol. 72:9706-9713.
9. Flomenberg, P., V. Piaskowski, R. L. Truitt, and J. T. Casper. 1995. Characterization of human proliferative T cells response to adenoviruses. J. Infect Dis. 171:1090-1096.
10. Francois, A., C. Chevalier, B. Delmas, N. Eterradossi, D. Toquin, G. Rivallan, and P. Langlois. 2004. Avian adenovirus CELO recombinants expressing VP2 of infectious bursal disease virus induce protection against bursal disease in chicken. Vaccine 22:2351-2360.
11. Gu, W., A. Ogose, H. Kawashima, M. Ito, T. Ito, A. Matsuba, H. Kitahara, T. Hotta, K. Tokunaga, H. Hatano, T. Morita, S. Urakawa, T. Yoshizawa, H. Kawashima, R. Kuwano, and N. Endo. 2004. High-level expression of the coxsackievirus and adenovirus receptor messenger RNA in osteosarcoma, Ewing's sarcoma, and benign neurogenic tumors among musculoskeletal tumors. Clin. Cancer Res. 10:3831-3838.
12. Han, Z. S., Q. W. Li, Z. Y. Zhang, B. Xiao, D. W. Gao, S. Y. Wu, J. Li, H. W. Zhao, Z. L. Jiang, and J. H. Hu. 2007. High-level expression of human lactoferrin in the milk of goats by using replication-defective adenoviral vectors. Protein Expr. Purif. 1:225-231.
13. Harvey, B. G., N. R. Hackett, T. El-Sawy, T. K. Rosengart, E. A. Hirschowitz, M. D. Lieberman, M. L. Lesser, and R. G. Crystal. 1999. Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs. J. Virol. 73:6729-6742.
14. Hemminki, A., N. Belousova, K. R. Zinn, B. Liu, M. Wang, T. R. Chaudhuri, B. E. Rogers, D. J. Buchsbaum, G. P. Siegal, M. N. Barnes, J. Gomez-Navarro, D. T. Curiel, and R. D. Alvarez. 2001. An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expression. Mol. Ther. 4:223-231.
15. Huang, S., T. Kamata, Y. Takada, Z. M. Ruggeri, and G. R. Nemerow. 1996. Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells. J. Virol. 70:4502-4508.
16. Jones, D. T. 1999. Protein secondary structure prediction based on position-specific scoring matrices. J. Mol. Biol. 292:195-202.
17. Kasono, K., J. L. Blackwell, J. T. Douglas, I. Dmitriev, T. V. Strong, P. Reynolds, D. A. Kropf, W. R. Carroll, G. E. Peters, R. P. Bucy, D. T. Curiel, and V. Krasnykh. 1999. Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector. Clin. Cancer Res. 5:2571-2579.
18. Kass-Eisler, A., E. Falck-Pedersen, D. H. Elfenbein, M. Alvira, P. M. Buttrick, and L. A. Leinwand. 1994. The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Ther. 1:395-402.
19. Krasnykh, V., I. Dmitriev, G. Mikheeva, C. R. Miller, N. Belousova, and D. T. Curiel. 1998. Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob. J. Virol. 72:1844-1852.
20. Le Gal La Salle, G., J. J. Robert, S. Berrard, V. Ridoux, L. D. Stratford-Perricaudet, M. Perricaudet, and J. Mallet. 1993. An adenovirus vector for gene transfer into neurons and glia in the brain. Science 259:988-990.
21. Li, E., S. L. Brown, D. G. Stupack, X. S. Puente, D. A. Cheresh, and G. R. Nemerow. 2001. Integrin αvβ1 is an adenovirus coreceptor. J. Virol. 75:5405-5409.
22. Li, Y., R. C. Pong, J. M. Bergelson, M. C. Hall, A. I. Sagalowsky, C. P. Tseng, Z. Wang, and J. T. Hsieh. 1999. Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy. Cancer Res. 59:325-330.
23. Liu, Y., T. Ye, J. Maynard, H. Akbulut, and A. Deisseroth. 2006. Engineering conditionally replication-competent adenoviral vectors carrying the cytosine deaminase gene increases the infectivity and therapeutic effect for breast cancer gene therapy. Cancer Gene Ther. 4:346-356.
24. Logunov, D. Y., G. V. Uyinskaya, L. V. Cherenova, L. V. Verhovskaya, M. M. Shmarov, P. M. Chumakov, B. P. Kopnin, and B. S. Naroditsky. 2004. Restoration of p53 tumor-suppressor activity in human tumor cells in vitro and in their xenografts in vivo by recombinant avian adenovirus CELO-p53. Gene Ther. 1:79-84.
25. Michou, A. L., H. Lehrmann, M. Saltik, and M. Cotten. 1999. Mutational analysis of the avian adenovirus CELO, which provides a basis for gene delivery vectors. J. Virol. 73:1399-1410.
26. Miller, C. R., D. J. Buchsbaum, P. N. Reynolds, J. T. Douglas, G. Y. Gillespie, M. S. Mayo, D. Raben, and D. T. Curiel. 1998. Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer. Cancer Res. 58:5738-5748.
27. Pasch, A., J. Kupper, A. Wolde, R. Kandolf, and H. Selinka. 1999. Comparative analysis of virus-host cell interactions of haemagglutinating and non-haemagglutinating strains of coxsackievirus B3. J. Gen. Virol. 80:3153-3158.
28. Rebel, V. I., S. Hartnett, J. Denham, M. Chan, R. Finberg, and C. A. Sieff. 2000. Maturation and lineage-specific expression of the coxsackie and adenovirus receptor in hematopoietic cells. Stem Cells 18:176-182.
29. Rosenfeld, M. A., K. Yoshimura, B. C. Trapnell, K. Yoneyama, E. R. Rosenthal, W. Dalemans, M. Fukayama, J. Bargon, L. E. Stier, L. Stratford-Perricaudet, et al. 1992. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68:143-155.
30. Seidman, M. A., S. M. Hogan, R. L. Wendland, S. Worgall, R. G. Crystal, and P. L. Leopold. 2001. Variation in adenovirus receptor expression and adenovirus vector mediated transgene expression at defined stages of the cell cycle. Mol. Ther. 4:13-21.
31. Shayakhmetov, D. M., A. M. Eberly, Z. Y. Li, and A. Lieber. 2005. Deletion of penton RGD motifs affects the efficiency of both the internalization and the endosome escape of viral particles containing adenovirus serotype 5 or 35 fiber knob. J. Virol. 79:1053-1061.
32. Shayakhmetov, D. M., Z. Y. Li, S. Ni, and A. Lieber. 2002. Targeting of adenovirus vectors to tumor cells does not enable efficient transduction of breast cancer metastases. Cancer Res. 62:1063-1068.
33. Smith, C. A., L. S. Woodruff, C. Rooney, and G. R. Kitchigan. 1998. Extensive cross-reactivitry of adenovirus-specific cytotoxic T cell. Hum. Gene Ther. 9:1419-1427.
34. Stevenson, M., E. Boos, C. Herbert, A. Hale, N. Green, M. Lyons, L. Chandler, K. Ulbrich, N. van Rooijen, V. Mautner, K. Fisher, and L. Seymour. 2006. Chick Lethal Orphan (CELO) virus can be polymer-coated and retargeted to infect mammalian cells. Gene Ther. 4:356-368.
35. Tan, P. K., A. Michou, J. M. Bergelson, and M. Cotten. 2001. Defining CAR as a cellular receptor for the avian adenovirus CELO using a genetic analysis of the two viral fibre proteins. J. Gen. Virol. 82:1465-1472.
36. Wickham, T. J., E. J. Filardo, D. A. Cheresh, and G. R. Nemerow. 1994. Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization. J. Cell Biol. 127:257-264.
37. Wickham, T. J., E. Tzeng, L. L. Shears II, P. W. Roelvink, Y. Li, G. M. Lee, D. E. Brough, A. Lizonova, and I. Kovesdi. 1997. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins. J. Virol. 71:8221-8229.
38. Wickham, T. J., P. Mathias, D. A. Cheresh, and G. R. Nemerow. 1993. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 73:309-319.
39. Wickham, T. J., P. W. Roelvink, D. E. Brough, and I. Kovesdi. 1996. Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types. Nat. Biotechnol. 14:1570-1573.
40. Wickham, T. J., D. M. Segal, P. W. Roelvink, M. E. Carrion, A. Lizonova, G. M. Lee, and I. Kovesdi. 1996. Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies. J. Virol. 70:6831-6838.
41. Wickham, T. J., M. E. Carrion, and I. Kovesdi. 1995. Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs. Gene Ther. 2:750-756.
42. Xia, D., L. J. Henry, R. D. Gerard, and J. Deisenhofer. 1994. Crystal structure of the receptor-binding domain of adenovirus type 5 fiber protein at 1.7 Å resolution. Structure 12:1259-1270.
43. Yang, Y., Q. Li, H. C. Ertl, and J. M. Wilson. 1995. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:2004-2015.